{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:02:24Z","timestamp":1792004544741,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Progres Q38\/LF1"},{"name":"MH CZ DRO 64165"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00059-017-4645-3","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T14:20:04Z","timestamp":1510842004000},"page":"347-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy","Osteopontinspiegel im Plasma bei dilatativer und hypertrophischer Kardiomyopathie"],"prefix":"10.1007","volume":"44","author":[{"given":"J.","family":"Podzimkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Palecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kuchynka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Danek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jachymova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kalousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"4645_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/01.HYP.0000148459.25908.49","volume":"112","author":"EM Gravallese","year":"2003","unstructured":"Gravallese EM (2003) Osteopontin: a\u00a0bridge between bone and the immune system. J\u00a0Clin Invest 112:147\u2013149. https:\/\/doi.org\/10.1161\/01.HYP.0000148459.25908.49","journal-title":"J Clin Invest"},{"key":"4645_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0030-1251504","volume":"36","author":"K Klingel","year":"2010","unstructured":"Klingel K, Kandolf R (2010) Osteopontin: a biomarker to predict the outcome of inflammatory heart disease. Semin Thromb Hemost 36:195\u2013202. https:\/\/doi.org\/10.1055\/s-0030-1251504","journal-title":"Semin Thromb Hemost"},{"key":"4645_CR3","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.1073\/pnas.83.23.8819","volume":"83","author":"A Oldberg","year":"1986","unstructured":"Oldberg A, Franz\u00e9n A, Heineg\u00e5rd D (1986) Cloning\u00a0and\u00a0sequence analysis\u00a0of\u00a0rat\u00a0bone\u00a0sialoprotein (osteopontin)\u00a0cDNA\u00a0reveals an Arg-Gly-Asp cell-binding\u00a0sequence. Proc Natl Acad Sci USA 83:8819\u20138823","journal-title":"Proc Natl Acad Sci USA"},{"key":"4645_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1161\/01.HYP.0000148459.25908.49","volume":"44","author":"K Graf","year":"2004","unstructured":"Graf K, Stawowy P (2004) Osteopontin: a\u00a0protective\u00a0mediator\u00a0of\u00a0cardiac\u00a0fibrosis? Hypertension 44:809\u2013810. https:\/\/doi.org\/10.1161\/01.HYP.0000148459.25908.49","journal-title":"Hypertension"},{"key":"4645_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12026-010-8179-5","volume":"49","author":"M Inoue","year":"2011","unstructured":"Inoue M, Shinohara ML (2011) Intracellular\u00a0osteopontin\u00a0(iOPN) and\u00a0immunity. Immunol Res 49:160\u2013172. https:\/\/doi.org\/10.1007\/s12026-010-8179-5","journal-title":"Immunol Res"},{"key":"4645_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/qjmed\/95.1.3","volume":"95","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kipari T, Ophascharoensuk V et al (2002) Osteopontin \u2013 a\u00a0molecule for all seasons. QJM 95:3\u201313","journal-title":"QJM"},{"key":"4645_CR7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4049\/jimmunol.162.2.1024","volume":"162","author":"AW O\u2019Regan","year":"1999","unstructured":"O\u2019Regan AW, Chupp GL, Lowry JA et al (1999) Osteopontin\u00a0is\u00a0associated\u00a0with\u00a0T\u00a0cells\u00a0in\u00a0sarcoid\u00a0granulomas and has\u00a0T\u00a0cell adhesive and cytokine-like properties in vitro. J\u00a0Immunol 162:1024\u20131031","journal-title":"J Immunol"},{"key":"4645_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.yjmcc.2009.06.015","volume":"48","author":"M Singh","year":"2009","unstructured":"Singh M, Foster CR, Dalal S, Singh K (2009) Osteopontin:\u00a0role\u00a0in\u00a0extracellular matrix\u00a0deposition\u00a0and myocardial remodelling post-MI. J\u00a0Mol Cell Cardiol 48:538\u2013543. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.06.015","journal-title":"J Mol Cell Cardiol"},{"key":"4645_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10741-010-9158-6","volume":"15","author":"M Singh","year":"2010","unstructured":"Singh M, Foster CR, Dalal S, Singh K (2010) Role\u00a0of\u00a0osteopontin\u00a0in\u00a0heart\u00a0failure\u00a0associated with\u00a0aging. Heart Fail Rev 15:487\u2013494. https:\/\/doi.org\/10.1007\/s10741-010-9158-6","journal-title":"Heart Fail Rev"},{"key":"4645_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2014.09.014","volume":"118","author":"M Singh","year":"2014","unstructured":"Singh M, Dalal S, Singh K (2014) Osteopontin: at the cross-roads of\u00a0myocyte\u00a0survival\u00a0and myocardial function. Life Sci 118:1\u20136. https:\/\/doi.org\/10.1016\/j.lfs.2014.09.014","journal-title":"Life Sci"},{"key":"4645_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/01.HYP.33.2.663","volume":"33","author":"K Singh","year":"1999","unstructured":"Singh K, Sirokman G, Communal C et al (1999) Myocardial\u00a0osteopontin\u00a0expression\u00a0coincides\u00a0with the\u00a0development\u00a0of\u00a0heart failure. Hypertension 33:663\u2013670","journal-title":"Hypertension"},{"key":"4645_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/eurjhf\/hft112","volume":"15","author":"M Behnes","year":"2013","unstructured":"Behnes M, Brueckmann M, Lang S et al (2013) Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure. Eur J Heart Fail 15:1390\u20131400. https:\/\/doi.org\/10.1093\/eurjhf\/hft112","journal-title":"Eur J Heart Fail"},{"key":"4645_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1388-9842(01)00237-9","volume":"4","author":"P Stawowy","year":"2002","unstructured":"Stawowy P, Blaschke F, Pfautsch P et al (2002) Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 4:139\u2013146","journal-title":"Eur J Heart Fail"},{"key":"4645_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCHEARTFAILURE.107.746172","volume":"1","author":"M Rosenberg","year":"2008","unstructured":"Rosenberg M, Zugck C, Nelles M et al (2008) Osteopontin, a\u00a0new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail 1:43\u201349. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.107.746172","journal-title":"Circ Heart Fail"},{"key":"4645_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ejheart.2004.10.019","volume":"7","author":"M Satoh","year":"2005","unstructured":"Satoh M, Nakamura M, Akatsu T et al (2005) Myocardial osteopontin expression is associated with collagen\u00a0fibrillogenesis\u00a0in human dilated cardiomyopathy. Eur J Heart Fail 7:755\u2013762. https:\/\/doi.org\/10.1016\/j.ejheart.2004.10.019","journal-title":"Eur J Heart Fail"},{"key":"4645_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a\u00a0position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart\u00a0J 29:270\u2013276. https:\/\/doi.org\/10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"key":"4645_CR17","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart\u00a0J 35:2733\u20132779. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284","journal-title":"Eur Heart J"},{"key":"4645_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"4645_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013270. https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"4645_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450\u2013458","journal-title":"Am J Cardiol"},{"key":"4645_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","volume":"10","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC et al (2009) Evaluation of left ventricular diastolic function by echocardiography: EAE\/ASE Recommendations. Eur J Echocardiogr 10:165\u2013193. https:\/\/doi.org\/10.1093\/ejechocard\/jep007","journal-title":"Eur J Echocardiogr"},{"key":"4645_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J et al (2010) Echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography and the Canadian Society of Echocardiography. J\u00a0Am Soc Echocardiogr 23:685\u2013713. https:\/\/doi.org\/10.1016\/j.echo.2010.05.010","journal-title":"J Am Soc Echocardiogr"},{"key":"4645_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ijcard.2010.08.048","volume":"153","author":"P Francia","year":"2011","unstructured":"Francia P, Balla C, Ricotta A et al (2011) Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in\u00a0heart\u00a0failure. Int J Cardiol 153:306\u2013310. https:\/\/doi.org\/10.1016\/j.ijcard.2010.08.048","journal-title":"Int J Cardiol"},{"key":"4645_CR24","first-page":"247","volume":"28","author":"DW Tang","year":"2012","unstructured":"Tang DW, Lin GS, Huang JL et al (2012) Changes of left ventricular myocardial collagen fibres and\u00a0osteopontin\u00a0expression in\u00a0hypertrophic cardiomyopathy. Fa Yi Xue Za Zhi 28:247\u2013251","journal-title":"Fa Yi Xue Za Zhi"},{"key":"4645_CR25","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1136\/hrt.2005.081406","volume":"92","author":"J Arnl\u00f6v","year":"2006","unstructured":"Arnl\u00f6v J, Evans JC, Benjamin EJ et al (2006) Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study. Heart 92:1514\u20131515. https:\/\/doi.org\/10.1136\/hrt.2005.081406","journal-title":"Heart"},{"key":"4645_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S (2016) Chronic\u00a0heart failure\u00a0and\u00a0inflammation: what do we really know? Circ Res 119:159\u2013176. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308030","journal-title":"Circ Res"},{"key":"4645_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/hrt.2002.007005","volume":"90","author":"SD Anker","year":"2004","unstructured":"Anker SD, von Haehling S (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90:464\u2013470. https:\/\/doi.org\/10.1136\/hrt.2002.007005","journal-title":"Heart"},{"key":"4645_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10741-006-9196-2","volume":"11","author":"A Yndestad","year":"2006","unstructured":"Yndestad A, Dam\u00e5s JK, Oie E et al (2006) Systemic inflammation in heart failure \u2013 The whys and wherefores. Heart Fail Rev 11:83\u201392. https:\/\/doi.org\/10.1007\/s10741-006-9196-2","journal-title":"Heart Fail Rev"},{"key":"4645_CR29","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","volume":"112","author":"IS Anand","year":"2005","unstructured":"Anand IS, Latini R, Florea VG et al (2005) C\u2011reactive protein in heart failure. Prognostic value and the effect of valsartan. Circulation 112:1428\u20131434. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.508465","journal-title":"Circulation"},{"key":"4645_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/CIRCRESAHA.109.193805","volume":"104","author":"G Szalay","year":"2009","unstructured":"Szalay G, Sauter M, Haberland M et al (2009) Osteopontin: a\u00a0fibrosis-related marker molecule in cardiac\u00a0remodeling\u00a0of\u00a0enterovirus\u00a0myocarditis\u00a0in the\u00a0susceptible\u00a0host. Circ Res 104:851\u2013859. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.193805","journal-title":"Circ Res"},{"key":"4645_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/CIRCHEARTFAILURE.109.898114","volume":"3","author":"MA Renault","year":"2010","unstructured":"Renault MA, Robbesyn F, R\u00e9ant P et al (2010) Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail 3:431\u2013439.\u00a0 https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.898114","journal-title":"Circ Heart Fail"},{"key":"4645_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1292\/jvms.68.379","volume":"68","author":"T Shin","year":"2006","unstructured":"Shin T, Ahn M, Kim H et al (2006) Increased expression of osteopontin in the heart tissue of Lewis rats\u00a0with\u00a0experimental\u00a0autoimmune myocarditis. J\u00a0Vet Med Sci 68:379\u2013382","journal-title":"J Vet Med Sci"},{"key":"4645_CR33","first-page":"546","volume":"57","author":"F Schoensiegel","year":"2007","unstructured":"Schoensiegel F, Bekeredjian R, Schrewe A et al (2007) Atrial natriuretic peptide and osteopontin are useful markers of cardiac disorders in mice. Comp Med 57:546\u2013553","journal-title":"Comp Med"},{"key":"4645_CR34","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jacc.2008.01.011","volume":"51","author":"M Bujak","year":"2008","unstructured":"Bujak M, Kweon HJ, Chatila K et al (2008) Aging-related defects are associated with adverse cardiac remodeling in a\u00a0mouse model of reperfused myocardial infarction. J\u00a0Am Coll Cardiol 51:1384\u20131392. https:\/\/doi.org\/10.1016\/j.jacc.2008.01.011","journal-title":"J Am Coll Cardiol"},{"key":"4645_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-008-9905-3","volume":"322","author":"BI Jugdutt","year":"2009","unstructured":"Jugdutt BI, Palaniyappan A, Uwiera RR, Idikio H (2009) Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs. Mol Cell Biochem 322:25\u201336. https:\/\/doi.org\/10.1007\/s11010-008-9905-3","journal-title":"Mol Cell Biochem"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4645-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-017-4645-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4645-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:23:06Z","timestamp":1693239786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-017-4645-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4645"],"URL":"https:\/\/doi.org\/10.1007\/s00059-017-4645-3","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"assertion":[{"value":"20 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"J.\u00a0Podzimkova, T.\u00a0Palecek, P.\u00a0Kuchynka, J.\u00a0Marek, B.A.\u00a0Danek, M.\u00a0Jachymova, M.\u00a0Kalousova, T.\u00a0Zima, and A.\u00a0Linhart declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}